Provided by Tiger Trade Technology Pte. Ltd.

Verastem

7.43
-0.1900-2.49%
Volume:831.88K
Turnover:6.20M
Market Cap:672.89M
PE:-3.08
High:7.79
Open:7.75
Low:7.32
Close:7.62
52wk High:10.82
52wk Low:3.43
Shares:90.56M
Float Shares:70.57M
Volume Ratio:0.34
T/O Rate:1.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4143
EPS(LYR):-3.0223
ROE:-471.16%
ROA:-49.59%
PB:13.46
PE(LYR):-2.46

Loading ...

Verastem Says Avmapki, Fakzynja Combination Sustains Benefits for 2 Years in Ovarian Cancer

MT Newswires Live
·
Apr 10

BRIEF-Verastem Oncology Announces Two-Year Median Follow-Up Data On Avmapki® Fakzynja® Combination Therapy

Reuters
·
Apr 10

Verastem says RAMP 201 shows durable benefit for AVMAPKI-FAKZYNJA in recurrent ovarian cancer

Reuters
·
Apr 10

Verastem Oncology Announces Two-Year Median Follow-up Data on Avmapki® Fakzynja® Combination Therapy (Avutometinib Capsules; Defactinib Tablets) in Recurrent Low-Grade Serous Ovarian Cancer at the Sgo 2026 Annual Meeting on Women’s Cancers

THOMSON REUTERS
·
Apr 10

RBC Capital Sticks to Their Buy Rating for Verastem (VSTM)

TIPRANKS
·
Apr 09

GenFleet says China grants breakthrough designation for GFH375 in metastatic pancreatic cancer

Reuters
·
Apr 09

BRIEF-Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Apr 03

Verastem Oncology grants 141,000 restricted stock units to 11 new employees

Reuters
·
Apr 03

Verastem Coverage Assumed by Jefferies at Buy

Dow Jones
·
Mar 31

Verastem assumed with a Buy at Jefferies

TIPRANKS
·
Mar 30

Verastem management to meet with Cantor

TIPRANKS
·
Mar 27

GenFleet FY2025 net loss widens to RMB 1.79 billion as revenue rises 24.41% to RMB 130 million

Reuters
·
Mar 25

Mizuho Securities Remains a Buy on Verastem (VSTM)

TIPRANKS
·
Mar 20

Verastem Oncology to present VS-7375 data at AACR Annual Meeting 2026

Reuters
·
Mar 18

Verastem to present long-term Phase 2 RAMP 201 data on avutometinib plus defactinib in recurrent low-grade serous ovarian cancer at SGO 2026

Reuters
·
Mar 18

Verastem Oncology to present AVMAPKI-FAKZYNJA combination data at SGO 2026 Annual Meeting on Women’s Cancers

Reuters
·
Mar 18